Cargando…
Effect of moxibustion on mTOR-mediated autophagy in rotenone-induced Parkinson's disease model rats
Defects in autophagy-mediated clearance of α-synuclein may be one of the key factors leading to progressive loss of dopaminergic neurons in the substantia nigra. Moxibustion therapy for Parkinson's disease has been shown to have a positive effect, but the underlying mechanism remains unknown. B...
Autores principales: | Wang, Shu-ju, Wang, Qi, Ma, Jun, Yu, Pei-hao, Wang, Zhong-ming, Wang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5840976/ https://www.ncbi.nlm.nih.gov/pubmed/29451215 http://dx.doi.org/10.4103/1673-5374.224380 |
Ejemplares similares
-
Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson’s Disease Models
por: Zhang, Yu, et al.
Publicado: (2019) -
Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways
por: Zhou, Qian, et al.
Publicado: (2016) -
Moxibustion Improves Chronic Heart Failure by Inhibiting Autophagy and Inflammation via Upregulation of mTOR Expression
por: Li, Qingling, et al.
Publicado: (2021) -
Balancing mTOR Signaling and Autophagy in the Treatment of Parkinson’s Disease
por: Zhu, Zhou, et al.
Publicado: (2019) -
Apelin-13 Protects Dopaminergic Neurons against Rotenone—Induced Neurotoxicity through the AMPK/mTOR/ULK-1 Mediated Autophagy Activation
por: Chen, Peng, et al.
Publicado: (2020)